Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium.
about
Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled TrialDelayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali.Severe delayed autoimmune haemolytic anaemia following artesunate administration in severe malaria: a case report.Retrospective study of imported falciparum malaria in French paediatric intensive care units.Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study.Management of imported malaria in Europe.Malaria: an update on current chemotherapy.Treating severe malaria in pregnancy: a review of the evidenceSevere imported falciparum malaria among adults requiring intensive care: a retrospective study at the hospital for tropical diseases, LondonAn imported case of severe falciparum malaria with prolonged hemolytic anemia clinically mimicking a coinfection with babesiosis.Management of severe paediatric malaria in resource-limited settings.Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013Severe falciparum malaria treated with artesunate complicated by delayed onset haemolysis and acute kidney injury.Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children.Severe falciparum malaria complicated by prolonged haemolysis and rhinomaxillary mucormycosis after parasite clearance: a case report.Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.Intravenous Artesunate for the Treatment of Severe and Complicated Malaria in the United States: Clinical Use Under an Investigational New Drug Protocol.Artesunate treatment of severe pediatric malaria: A review of parasite clearance kinetics and clinical implications.Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: phase 1b studyThe prognostic value of schizontaemia in imported Plasmodium falciparum malaria.Advances in the treatment of malariaManual blood exchange transfusion does not significantly contribute to parasite clearance in artesunate-treated individuals with imported severe Plasmodium falciparum malariaArtesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysisTherapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under.Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.Intravascular haemolysis with haemoglobinuria in a splenectomized patient with severe Plasmodium knowlesi malaria.Roll out of intraveneous artesunate under named patient programmes in the Netherlands, Belgium and France.Severe malaria in Europe: an 8-year multi-centre observational study.Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria -associated anaemia in Nigerian children during seven years of adoption as first-line treatmentsNovel anti-malarial combinations and their toxicity.Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study.Artesunate to treat severe malaria in travellers: review of efficacy and safety and practical implications.Development of Delayed Hemolytic Anemia After Treatment with Oral Artemether-Lumefantrine in Two Patients with Severe Falciparum Malaria.Delayed Hemolysis After Parenteral Artesunate Therapy for Severe Malaria in Two Returning Canadian Travelers.Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria.Severe delayed hemolysis associated with regulated parenteral antimalarial drug.A continuous-flow process for the synthesis of artemisinin.Current challenges in travelers' malaria.Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria--worldwide, 2010-2012.
P2860
Q28552379-BCB6EC5E-20F4-4916-8435-E29D8F8423D4Q30850979-DFC9B997-7A36-46C1-B69B-426C8D965D5CQ33418146-5B788CAB-F658-4199-8B15-E59336DFE8D5Q33432904-541F7D13-BC84-4EAD-A768-041AD2D937D5Q33886869-6E33781D-4D7B-4FD2-BEF9-F9ACBA1EBAA7Q33958541-87DF5300-8254-46B4-818A-DA95A810FA9BQ34300222-16FCF155-515C-412C-A3AC-26C0894593ACQ34433106-E600915B-A1A8-425E-BE06-8723C9ECA7F2Q34456393-DA5503E6-DA72-4681-8F6E-883FCE2AEB54Q34622683-DE64628F-6868-4CAD-BCCD-26500022C363Q34775196-F35F585D-9950-4FBC-8AF1-D8B00F22CFF1Q35142564-885DA9FE-7344-4784-AAE1-D113FD3C78AEQ35546045-3A2F0B5C-9893-4210-BFD8-7A4BEA6422E0Q35750308-7C0D3F05-92EC-4E44-A508-B1466A85AD0DQ35821563-F22B05A4-C276-43C4-AB77-FC1AF577EDE8Q35860379-A5FF8537-7B40-4E39-8B6B-8F54B92F3D70Q36035590-F3000988-6F38-47E7-B154-BE44D76B7BCBQ36232538-99782FC3-B462-49B8-9590-9F5735DF2E9AQ36277347-8FD9A77B-029C-4F3F-8EA7-54D5885D4689Q36309099-244ADF04-BAFC-4965-8D1B-A997B9813562Q36372875-12784A0B-F3F5-4B7E-A55F-60EA6230AC9EQ36404786-12DA28BA-32EC-4AEF-86AD-02A86D0870B2Q36741273-3F4B4674-9BC3-4336-B853-2210A92B8554Q37033558-B126734C-A418-4632-8137-BA2548D7A191Q37067888-FFB2302B-9A4A-4A2A-96CD-CF7395DCA1B9Q37169837-AC133550-A468-4B64-B173-F342C291FB3AQ37243860-11EA2AB9-590B-470E-B037-421211A1AA91Q37360307-F579D197-AEC2-40C4-BC6A-9B7C82FCB59EQ37618634-BC630393-6869-4063-9AFF-16C5CB709281Q37628066-C74F2187-F2A5-4C95-9B11-B178FC271113Q38203334-F507A959-73EA-4827-A573-38D52B47AA97Q39153213-01AC11EE-F2BB-4C29-BAB7-735A195E98E9Q39232091-80FF32DC-1E6A-4989-AAA7-7228E069B593Q39536124-A9F1BCD0-4A51-42DD-BC83-19F05E16E07AQ41073549-755EE7D8-01A1-422C-9D1D-AE515ABFF235Q42268263-7FC00F87-FA18-48D5-B00B-BE895B238358Q43092865-67A489E8-C057-4080-BD5E-1504559E8A27Q44347957-F4728C52-3AF6-435D-8CDF-B82A39981808Q45193734-AE5F04BE-64AA-4EC1-87D3-062D8F7B6283Q46364770-7113810B-B7FA-43A6-9720-9B687EA99F9C
P2860
Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Treatment outcome of intraveno ...... in the Netherlands and Belgium
@nl
Treatment outcome of intraveno ...... n the Netherlands and Belgium.
@ast
Treatment outcome of intraveno ...... n the Netherlands and Belgium.
@en
Treatment outcome of intraveno ...... n the Netherlands and Belgium.
@en-gb
type
label
Treatment outcome of intraveno ...... in the Netherlands and Belgium
@nl
Treatment outcome of intraveno ...... n the Netherlands and Belgium.
@ast
Treatment outcome of intraveno ...... n the Netherlands and Belgium.
@en
Treatment outcome of intraveno ...... n the Netherlands and Belgium.
@en-gb
prefLabel
Treatment outcome of intraveno ...... in the Netherlands and Belgium
@nl
Treatment outcome of intraveno ...... n the Netherlands and Belgium.
@ast
Treatment outcome of intraveno ...... n the Netherlands and Belgium.
@en
Treatment outcome of intraveno ...... n the Netherlands and Belgium.
@en-gb
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Treatment outcome of intraveno ...... n the Netherlands and Belgium.
@en
P2093
Annemarie R Kreeftmeijer-Vegter
Cees K W van Veldhuizen
Peter J de Vries
Wouter F W Bierman
P2860
P2888
P3181
P356
10.1186/1475-2875-11-102
P407
P577
2012-03-31T00:00:00Z
P5875
P6179
1023741019